Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes Mellitus (T2DM)

NCT00456352 is registered in ClinicalTrials.gov with Medtronic - MITG as lead sponsor.

NCT NCT00456352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00456352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes Mellitus (T2DM)
Lead sponsor
Medtronic - MITG
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
October 31, 2010
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes